Ponce-de-Leon, M.* ; Wang-Sattler, R. ; Peters, A. ; Rathmann, W.* ; Grallert, H. ; Artati, A. ; Prehn, C. ; Adamski, J. ; Meisinger, C.* ; Linseisen, J.*
Stool and blood metabolomics in the metabolic syndrome: A cross-sectional study.
Metabolomics 20:105 (2024)
INTRODUCTION/OBJECTIVES: Changes in the stool metabolome have been poorly studied in the metabolic syndrome (MetS). Moreover, few studies have explored the relationship of stool metabolites with circulating metabolites. Here, we investigated the associations between stool and blood metabolites, the MetS and systemic inflammation. METHODS: We analyzed data from 1,370 participants of the KORA FF4 study (Germany). Metabolites were measured by Metabolon, Inc. (untargeted) in stool, and using the AbsoluteIDQ® p180 kit (targeted) in blood. Multiple linear regression models, adjusted for dietary pattern, age, sex, physical activity, smoking status and alcohol intake, were used to estimate the associations of metabolites with the MetS, its components and high-sensitivity C-reactive protein (hsCRP) levels. Partial correlation and Multi-Omics Factor Analysis (MOFA) were used to investigate the relationship between stool and blood metabolites. RESULTS: The MetS was significantly associated with 170 stool and 82 blood metabolites. The MetS components with the highest number of associations were triglyceride levels (stool) and HDL levels (blood). Additionally, 107 and 27 MetS-associated metabolites (in stool and blood, respectively) showed significant associations with hsCRP levels. We found low partial correlation coefficients between stool and blood metabolites. MOFA did not detect shared variation across the two datasets. CONCLUSIONS: The MetS, particularly dyslipidemia, is associated with multiple stool and blood metabolites that are also associated with systemic inflammation. Further studies are necessary to validate our findings and to characterize metabolic alterations in the MetS. Although our analyses point to weak correlations between stool and blood metabolites, additional studies using integrative approaches are warranted.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Blood Metabolomics ; Metabolic Syndrome ; Stool Metabolomics ; Systemic Inflammation; Gut Microbiota; Acid-metabolism; Bile-acids; Plasma
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
1573-3882
e-ISSN
1573-3890
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 20,
Heft: 5,
Seiten: ,
Artikelnummer: 105
Supplement: ,
Reihe
Verlag
Springer
Verlagsort
New York, NY
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
30202 - Environmental Health
30505 - New Technologies for Biomedical Discoveries
30201 - Metabolic Health
Forschungsfeld(er)
Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e)
G-506700-001
G-504000-010
G-504091-002
A-630710-001
G-500600-001
G-504090-001
Förderungen
Projekt DEAL
Ludwig-Maximilians-Universitat Munchen, Germany
Munich Center of Health Sciences (MC-Health)
State of Bavaria
German Ministry of Education and Research (BMBF)
Helmholtz Munich - German Research Center for Environmental Health
Copyright
Erfassungsdatum
2024-09-27